shuyung wrote:
It sounds as if this girl is afflicted with some form of severe combined immunodeficiency. The different forms of SCID all appear to be treatable with a bone marrow transplant, the two most common by gene therapy. All treatments which seem to be at or below the cost of a year's worth of the injections you reference. Why does this girl need to receive these injections indefinitely?
So back to the injections. By your assumptions, 1000 people per month are required to keep this girl alive. Let's assume that they are all mercenary bastards and receive remuneration for their donations. If $10 of the amount they receive for their blood (and plasma) is for Ig(G probably), that means in the remaining $1k+ is found production, distribution, and profit. This breakdown is probably irreducible to lower cost, it's also probably the most unrealistic. $5? That leaves $6k+ for PDP. Reducible to some extent, probably still unrealistic. $1? Now we're getting somewhere. That leaves $10k+ for PDP. I don't know if you've noticed, but production and distribution costs, barring outside influence, only decrease over time. So what are the production and distribution costs for this injection today? Today vs. 10 years ago?
So to morals. Should 1000 people be on the hook for one person's life?
It's not SCID. SCID is quite different. I think a bone marrow transplant would still work but you have to find a matching donor and those still fatal about 1 time in 5. Beyond that, under a fully private system a bone marrow transplant would almost certainly be an automatic disqualification for receiving health insurance, leaving you screwed if any complications ever occur, or you ever get any other major illness ever again.
As far as the injections go, the blood donors are not paid. They're not "on the hook." However, if you want blood from a blood bank, you have to pay them for their costs of screening donors, taking the donations, testing the donations for bloodborne infection, storing the blood, and (sometimes) profit. Then you have to actually seperate the Ig from the plasma. You either have to do this under completely aseptic conditions, or you basically have to throw out the 1000 units of plasma after you're done because they are now contaminated. I'm not sure which one would be cheaper, but both add significant cost. Either you have to pay for the sterile equipment and process or you have to pay the blood bank extra because they're not getting usable blood plasma returned to them.
The thing is, as far as I know, intravenous Ig is not a patented product. That means there's no one company with a monopoly on it, meaning competition does exist. Probably not perfect competition, but assuming the cost would drop by 90% or something ridiculous is just totally unrealistic.